The STELLAR Phase 3 Trial: A Study of Sotatercept in Combination with Background Therapy for the Treatment of Pulmonary Arterial Hypertension
Host: Marius M. Hoeper, MD
\n\n\n \n
In this program, expert faculty discuss data presented at the 2023 ACC Congress in a concise, informative, on-demand format. This format extends the congress analysis to a broader audience with greater detail than what is available in abstracts. Rapid advances from the meeting require well-planned educational programming to bridge knowledge, competence, and performance gaps.